These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 33455473

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV, Katz E, Weitz B, Visconti K.
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A, Cleary E, Douglas E, Aujla R, Boyars L, Smith C, Guille C.
    Fam Pract; 2022 Mar 24; 39(2):311-315. PubMed ID: 34537839
    [Abstract] [Full Text] [Related]

  • 6. Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.
    Premkumar A, Grobman WA, Terplan M, Miller ES.
    Obstet Gynecol; 2019 Nov 24; 134(5):921-931. PubMed ID: 31599845
    [Abstract] [Full Text] [Related]

  • 7. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M.
    Addiction; 2018 Jul 24; 113(7):1286-1294. PubMed ID: 29443414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S, Martin PR.
    Am J Drug Alcohol Abuse; 2018 Jul 24; 44(3):310-316. PubMed ID: 28829626
    [Abstract] [Full Text] [Related]

  • 14. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
    Zedler BK, Mann AL, Kim MM, Amick HR, Joyce AR, Murrelle EL, Jones HE.
    Addiction; 2016 Dec 24; 111(12):2115-2128. PubMed ID: 27223595
    [Abstract] [Full Text] [Related]

  • 15. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
    Wang S, Meador KJ, Pawasauskas J, Lewkowitz AK, Ward KE, Brothers TN, Hartzema A, Quilliam BJ, Wen X.
    Drug Saf; 2023 Mar 24; 46(3):257-271. PubMed ID: 36642778
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL, Rayburn WF.
    Obstet Gynecol Clin North Am; 2014 Jun 24; 41(2):241-53. PubMed ID: 24845488
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.